INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$778K

$778,812

View Combined Trades

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-03-05 $239,427 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-03-05	$239,427	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-03-05 $210,804 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-03-05	$210,804	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-03-05 $165,541 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-03-05	$165,541	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-03-05 $163,040 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-03-05	$163,040	S	Form 4